Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Reardon Andrew. Insider active across 1 company, notably Ligand Pharmaceuticals INC. Aggregated, 49 filings have been logged. Split: 0 buy · 27 sells. Total volume traded: €3.6m. History available since 30 November 2022. The latest transaction was disclosed on 3 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Reardon Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
337 shares@ US$204.50261.6% of flowCommon StockSEC:0002001011-26-000037:6
25 of 49 declarations
About Reardon Andrew
Reardon Andrew has filed 38 disclosures in total. Across the 38 sampled filings, all concerning Ligand Pharmaceuticals INC, the transactions recorded between 2022-12-01 and 2026-07-06 are sales, with total sales of EUR 2363425 and no purchases.